60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.22% | 37.89% | -33.60% | 7.61% | 8.24% |
| Total Depreciation and Amortization | 9.75% | 3.51% | 15.74% | 17.26% | 5.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.26% | -188.38% | 57.92% | 20.45% | 5.24% |
| Change in Net Operating Assets | -2,183.83% | 116.66% | -446.42% | -43.44% | -62.77% |
| Cash from Operations | -61.99% | 19.75% | -45.45% | 9.22% | 2.49% |
| Capital Expenditure | 62.45% | -699.00% | 78.86% | -1,651.85% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 194.81% | -8,226.45% | -252.27% | -100.26% | 81,300.00% |
| Cash from Investing | 187.10% | -5,274.12% | 50.68% | -103.04% | 81,171.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 634.80% | -89.29% | -- | -100.00% | 171,390.00% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 634.80% | -89.29% | -- | -100.00% | 169,590.00% |
| Foreign Exchange rate Adjustments | 521.43% | -216.67% | -93.02% | 273.74% | -395.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.14% | -221.26% | 244.74% | -182.84% | 209.19% |